Topics:
Breast Cancer • Medical Oncology • NCI-CCC Tumor Board Question • Yale • HR+ • NCI-CCC Breast Tumor Board Question
How do you manage adjuvant endocrine therapy for microinvasive HR-positive disease measuring >=1mm in extension?